Insider holders · CIK 0001778016
NovaBridge Biosciences · NBP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Cong Claire XuEVP, Clinical Development | 304,201 | — | 304,201 | Sep 1, 2026 · 6:00 pm EDT | Form 4 |
| Sean Wuxiong CaoChief Bus. Development Officer | 266,467 | — | 266,467 | Sep 11, 2026 · 4:30 pm EDT | Form 4 |
| Phillip Andrew DennisChief Medical Officer | 173,427 | — | 173,427 | Sep 21, 2026 · 4:05 pm EDT | Form 4 |
| Robert A. LenzDirector | 17,218 | — | 17,218 | Aug 25, 2026 · 4:15 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.